Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review

Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are currently being investigated in trials as potential therapy for coronavirus disease 2019 (COVID-19). A thorough understanding of the current body of evidence regarding the ben...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Cochrane database of systematic reviews Ročník 7; s. CD013600
Hlavní autori:	Piechotta, Vanessa, Chai, Khai Li, Valk, Sarah J, Doree, Carolyn, Monsef, Ina, Wood, Erica M, Lamikanra, Abigail, Kimber, Catherine, McQuilten, Zoe, So-Osman, Cynthia, Estcourt, Lise J, Skoetz, Nicole
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 10.07.2020
Predmet:	Betacoronavirus - immunology Cause of Death Coronavirus Infections - immunology Coronavirus Infections - mortality Coronavirus Infections - therapy COVID-19 COVID-19 Serotherapy Early Termination of Clinical Trials Humans Immunization, Passive - adverse effects Immunization, Passive - methods Immunization, Passive - mortality Immunization, Passive - statistics & numerical data Non-Randomized Controlled Trials as Topic - mortality Non-Randomized Controlled Trials as Topic - statistics & numerical data Pandemics Pneumonia, Viral - immunology Pneumonia, Viral - mortality Pneumonia, Viral - therapy Randomized Controlled Trials as Topic - statistics & numerical data Respiration, Artificial - statistics & numerical data SARS-CoV-2 Selection Bias Severity of Illness Index Treatment Outcome
ISSN:	1469-493X, 1469-493X
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!